nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC22A3—coronary artery disease	0.11	0.426	CbGaD
Imipramine—HTR7—coronary artery disease	0.0698	0.27	CbGaD
Imipramine—Benazepril—Enalapril—coronary artery disease	0.058	0.282	CrCrCtD
Imipramine—Benazepril—Trandolapril—coronary artery disease	0.058	0.282	CrCrCtD
Imipramine—Benazepril—Lisinopril—coronary artery disease	0.0454	0.221	CrCrCtD
Imipramine—Benazepril—Ramipril—coronary artery disease	0.0439	0.214	CrCrCtD
Imipramine—CYP2C19—coronary artery disease	0.0433	0.168	CbGaD
Imipramine—HTR2A—coronary artery disease	0.0351	0.136	CbGaD
Imipramine—ORM1—Penbutolol—coronary artery disease	0.0224	0.0737	CbGbCtD
Imipramine—ORM1—Pitavastatin—coronary artery disease	0.0196	0.0644	CbGbCtD
Imipramine—HTR1A—Penbutolol—coronary artery disease	0.0146	0.0481	CbGbCtD
Imipramine—CYP2B6—Clopidogrel—coronary artery disease	0.00961	0.0316	CbGbCtD
Imipramine—CYP3A7—Eplerenone—coronary artery disease	0.00938	0.0309	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.00938	0.0309	CbGbCtD
Imipramine—ABCB1—Ticagrelor—coronary artery disease	0.00798	0.0263	CbGbCtD
Imipramine—KCND3—endocardium—coronary artery disease	0.00779	0.199	CbGeAlD
Imipramine—CYP2C19—Gemfibrozil—coronary artery disease	0.00704	0.0232	CbGbCtD
Imipramine—CYP1A2—Gemfibrozil—coronary artery disease	0.0065	0.0214	CbGbCtD
Imipramine—CYP2C19—Clopidogrel—coronary artery disease	0.00611	0.0201	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00605	0.0199	CbGbCtD
Imipramine—CYP3A7—Simvastatin—coronary artery disease	0.00605	0.0199	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00592	0.0195	CbGbCtD
Imipramine—CYP3A7—Lovastatin—coronary artery disease	0.00592	0.0195	CbGbCtD
Imipramine—CYP2B6—Simvastatin—coronary artery disease	0.00576	0.019	CbGbCtD
Imipramine—CYP1A2—Clopidogrel—coronary artery disease	0.00563	0.0186	CbGbCtD
Imipramine—KCNH2—purkinje fiber—coronary artery disease	0.00558	0.142	CbGeAlD
Imipramine—CYP3A7—Atorvastatin—coronary artery disease	0.00539	0.0177	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00539	0.0177	CbGbCtD
Imipramine—CYP2C19—Telmisartan—coronary artery disease	0.00534	0.0176	CbGbCtD
Imipramine—CYP2B6—Atorvastatin—coronary artery disease	0.00513	0.0169	CbGbCtD
Imipramine—ABCB1—Clopidogrel—coronary artery disease	0.00493	0.0162	CbGbCtD
Imipramine—ABCB1—Perindopril—coronary artery disease	0.00493	0.0162	CbGbCtD
Imipramine—CYP3A4—Ticagrelor—coronary artery disease	0.00478	0.0157	CbGbCtD
Imipramine—ABCB1—Pitavastatin—coronary artery disease	0.00431	0.0142	CbGbCtD
Imipramine—ABCB1—Telmisartan—coronary artery disease	0.00431	0.0142	CbGbCtD
Imipramine—CYP2C19—Timolol—coronary artery disease	0.0043	0.0142	CbGbCtD
Imipramine—CYP3A4—Fenofibrate—coronary artery disease	0.00426	0.014	CbGbCtD
Imipramine—ABCB1—Enalapril—coronary artery disease	0.00408	0.0134	CbGbCtD
Imipramine—ABCB1—Lisinopril—coronary artery disease	0.00408	0.0134	CbGbCtD
Imipramine—CYP2C19—Rosuvastatin—coronary artery disease	0.00393	0.013	CbGbCtD
Imipramine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00383	0.0126	CbGbCtD
Imipramine—CYP2C19—Simvastatin—coronary artery disease	0.00366	0.012	CbGbCtD
Imipramine—CYP2C19—Lovastatin—coronary artery disease	0.00358	0.0118	CbGbCtD
Imipramine—CYP2D6—Niacin—coronary artery disease	0.00352	0.0116	CbGbCtD
Imipramine—ABCB1—Timolol—coronary artery disease	0.00347	0.0114	CbGbCtD
Imipramine—CYP3A4—Gemfibrozil—coronary artery disease	0.0034	0.0112	CbGbCtD
Imipramine—CYP2D6—Timolol—coronary artery disease	0.00327	0.0108	CbGbCtD
Imipramine—CYP2C19—Atorvastatin—coronary artery disease	0.00326	0.0107	CbGbCtD
Imipramine—ABCB1—Ezetimibe—coronary artery disease	0.00317	0.0105	CbGbCtD
Imipramine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00309	0.0102	CbGbCtD
Imipramine—ABCB1—Captopril—coronary artery disease	0.00306	0.0101	CbGbCtD
Imipramine—CYP2C19—Losartan—coronary artery disease	0.00298	0.00982	CbGbCtD
Imipramine—CYP3A4—Clopidogrel—coronary artery disease	0.00295	0.00972	CbGbCtD
Imipramine—ABCB1—Simvastatin—coronary artery disease	0.00295	0.00972	CbGbCtD
Imipramine—ABCB1—Pravastatin—coronary artery disease	0.00289	0.00951	CbGbCtD
Imipramine—ABCB1—Lovastatin—coronary artery disease	0.00289	0.00951	CbGbCtD
Imipramine—CYP2D6—Captopril—coronary artery disease	0.00288	0.00948	CbGbCtD
Imipramine—KCNH2—endocardium—coronary artery disease	0.00288	0.0733	CbGeAlD
Imipramine—CYP2D6—Simvastatin—coronary artery disease	0.00278	0.00916	CbGbCtD
Imipramine—CYP1A2—Losartan—coronary artery disease	0.00275	0.00906	CbGbCtD
Imipramine—CYP3A4—Eplerenone—coronary artery disease	0.00274	0.00904	CbGbCtD
Imipramine—CYP2D6—Pravastatin—coronary artery disease	0.00272	0.00896	CbGbCtD
Imipramine—CYP2D6—Lovastatin—coronary artery disease	0.00272	0.00896	CbGbCtD
Imipramine—ABCB1—Atorvastatin—coronary artery disease	0.00263	0.00866	CbGbCtD
Imipramine—CYP2D6—Atorvastatin—coronary artery disease	0.00248	0.00816	CbGbCtD
Imipramine—CYP3A4—Enalapril—coronary artery disease	0.00245	0.00805	CbGbCtD
Imipramine—ABCB1—Losartan—coronary artery disease	0.00241	0.00792	CbGbCtD
Imipramine—CYP3A4—Ezetimibe—coronary artery disease	0.0019	0.00626	CbGbCtD
Imipramine—CYP3A4—Rosuvastatin—coronary artery disease	0.0019	0.00626	CbGbCtD
Imipramine—CYP3A4—Simvastatin—coronary artery disease	0.00177	0.00582	CbGbCtD
Imipramine—CYP3A4—Lovastatin—coronary artery disease	0.00173	0.0057	CbGbCtD
Imipramine—CYP3A4—Pravastatin—coronary artery disease	0.00173	0.0057	CbGbCtD
Imipramine—CYP3A4—Atorvastatin—coronary artery disease	0.00158	0.00519	CbGbCtD
Imipramine—CYP3A4—Losartan—coronary artery disease	0.00144	0.00475	CbGbCtD
Imipramine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00126	0.0322	CbGeAlD
Imipramine—HTR7—pulmonary artery—coronary artery disease	0.00125	0.0319	CbGeAlD
Imipramine—HTR7—sympathetic nervous system—coronary artery disease	0.00122	0.031	CbGeAlD
Imipramine—HTR2A—arteriole—coronary artery disease	0.00119	0.0303	CbGeAlD
Imipramine—HTR7—vagus nerve—coronary artery disease	0.00118	0.03	CbGeAlD
Imipramine—HTR7—vein—coronary artery disease	0.00114	0.029	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—coronary artery disease	0.000848	0.0216	CbGeAlD
Imipramine—HTR7—autonomic nervous system—coronary artery disease	0.000817	0.0208	CbGeAlD
Imipramine—HTR2A—pulmonary artery—coronary artery disease	0.000779	0.0199	CbGeAlD
Imipramine—HTR2A—sympathetic nervous system—coronary artery disease	0.000758	0.0193	CbGeAlD
Imipramine—KCND2—cardiac ventricle—coronary artery disease	0.000752	0.0192	CbGeAlD
Imipramine—HTR2A—vagus nerve—coronary artery disease	0.000734	0.0187	CbGeAlD
Imipramine—HTR2A—vein—coronary artery disease	0.000709	0.0181	CbGeAlD
Imipramine—KCND3—cardiac ventricle—coronary artery disease	0.000656	0.0167	CbGeAlD
Imipramine—KCND3—myocardium—coronary artery disease	0.000617	0.0157	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—coronary artery disease	0.00051	0.013	CbGeAlD
Imipramine—KCND2—heart—coronary artery disease	0.000494	0.0126	CbGeAlD
Imipramine—KCND2—cardiovascular system—coronary artery disease	0.000466	0.0119	CbGeAlD
Imipramine—HTR7—artery—coronary artery disease	0.000463	0.0118	CbGeAlD
Imipramine—KCND3—heart—coronary artery disease	0.000431	0.011	CbGeAlD
Imipramine—KCND3—cardiovascular system—coronary artery disease	0.000406	0.0104	CbGeAlD
Imipramine—HTR7—endothelium—coronary artery disease	0.000391	0.00998	CbGeAlD
Imipramine—KCND3—cardiac atrium—coronary artery disease	0.000368	0.00939	CbGeAlD
Imipramine—Olopatadine—S100B—coronary artery disease	0.0003	0.114	CrCbGaD
Imipramine—HTR2A—artery—coronary artery disease	0.000289	0.00737	CbGeAlD
Imipramine—HTR2A—endothelium—coronary artery disease	0.000244	0.00622	CbGeAlD
Imipramine—KCNH2—cardiac ventricle—coronary artery disease	0.000242	0.00617	CbGeAlD
Imipramine—Epinastine—HRH2—coronary artery disease	0.000232	0.0881	CrCbGaD
Imipramine—KCNH2—myocardium—coronary artery disease	0.000228	0.00581	CbGeAlD
Imipramine—SLC22A4—heart—coronary artery disease	0.000227	0.00579	CbGeAlD
Imipramine—CHRM2—heart—coronary artery disease	0.00022	0.00561	CbGeAlD
Imipramine—CHRM2—cardiovascular system—coronary artery disease	0.000208	0.00529	CbGeAlD
Imipramine—CHRM1—cardiovascular system—coronary artery disease	0.000189	0.00482	CbGeAlD
Imipramine—ORM1—blood—coronary artery disease	0.000176	0.00449	CbGeAlD
Imipramine—HTR7—heart—coronary artery disease	0.000171	0.00435	CbGeAlD
Imipramine—SLC22A4—blood—coronary artery disease	0.000169	0.00432	CbGeAlD
Imipramine—HTR1A—cardiovascular system—coronary artery disease	0.000168	0.0043	CbGeAlD
Imipramine—Carbamazepine—RALBP1—coronary artery disease	0.000167	0.0636	CrCbGaD
Imipramine—ADRA1A—heart—coronary artery disease	0.000165	0.0042	CbGeAlD
Imipramine—SLC22A1—blood—coronary artery disease	0.000161	0.00411	CbGeAlD
Imipramine—HTR7—cardiovascular system—coronary artery disease	0.000161	0.0041	CbGeAlD
Imipramine—KCNH2—heart—coronary artery disease	0.000159	0.00405	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—coronary artery disease	0.000155	0.00396	CbGeAlD
Imipramine—SLC6A4—blood—coronary artery disease	0.00015	0.00383	CbGeAlD
Imipramine—KCNH2—cardiovascular system—coronary artery disease	0.00015	0.00382	CbGeAlD
Imipramine—KCNH2—cardiac atrium—coronary artery disease	0.000136	0.00347	CbGeAlD
Imipramine—Mianserin—HRH2—coronary artery disease	0.000134	0.051	CrCbGaD
Imipramine—CYP2B6—heart—coronary artery disease	0.00013	0.00333	CbGeAlD
Imipramine—HTR7—blood—coronary artery disease	0.000127	0.00325	CbGeAlD
Imipramine—CYP2C19—blood—coronary artery disease	0.000124	0.00317	CbGeAlD
Imipramine—CYP2B6—cardiovascular system—coronary artery disease	0.000123	0.00314	CbGeAlD
Imipramine—ADRA1A—blood—coronary artery disease	0.000123	0.00313	CbGeAlD
Imipramine—Clomipramine—HRH2—coronary artery disease	0.000123	0.0466	CrCbGaD
Imipramine—KCNH2—blood—coronary artery disease	0.000119	0.00302	CbGeAlD
Imipramine—CYP2E1—cardiovascular system—coronary artery disease	0.000116	0.00295	CbGeAlD
Imipramine—Doxepin—HRH2—coronary artery disease	0.000107	0.0409	CrCbGaD
Imipramine—HTR2A—heart—coronary artery disease	0.000106	0.00271	CbGeAlD
Imipramine—CYP1A2—blood—coronary artery disease	0.000102	0.00259	CbGeAlD
Imipramine—HTR2A—cardiovascular system—coronary artery disease	0.0001	0.00256	CbGeAlD
Imipramine—Benazepril—MTHFR—coronary artery disease	9.84e-05	0.0374	CrCbGaD
Imipramine—CYP2B6—blood—coronary artery disease	9.73e-05	0.00248	CbGeAlD
Imipramine—CYP2E1—blood—coronary artery disease	9.14e-05	0.00233	CbGeAlD
Imipramine—Amitriptyline—HRH2—coronary artery disease	8.31e-05	0.0316	CrCbGaD
Imipramine—Benazepril—ACE—coronary artery disease	8.02e-05	0.0305	CrCbGaD
Imipramine—HTR2A—blood—coronary artery disease	7.94e-05	0.00202	CbGeAlD
Imipramine—Epinastine—HTR7—coronary artery disease	7.88e-05	0.03	CrCbGaD
Imipramine—CYP3A4—blood—coronary artery disease	7.35e-05	0.00187	CbGeAlD
Imipramine—CYP2D6—blood—coronary artery disease	7.23e-05	0.00184	CbGeAlD
Imipramine—ABCB1—heart—coronary artery disease	6.97e-05	0.00178	CbGeAlD
Imipramine—Maprotiline—HTR7—coronary artery disease	6.78e-05	0.0258	CrCbGaD
Imipramine—ABCB1—cardiovascular system—coronary artery disease	6.58e-05	0.00168	CbGeAlD
Imipramine—Desipramine—SLC22A3—coronary artery disease	5.28e-05	0.0201	CrCbGaD
Imipramine—ABCB1—blood—coronary artery disease	5.2e-05	0.00133	CbGeAlD
Imipramine—Clomipramine—GSTP1—coronary artery disease	5.09e-05	0.0194	CrCbGaD
Imipramine—Mianserin—HTR7—coronary artery disease	4.56e-05	0.0173	CrCbGaD
Imipramine—Oxcarbazepine—CYP2C19—coronary artery disease	4.5e-05	0.0171	CrCbGaD
Imipramine—Amitriptyline—OPRD1—coronary artery disease	4.39e-05	0.0167	CrCbGaD
Imipramine—Cyamemazine—HTR2A—coronary artery disease	4.29e-05	0.0163	CrCbGaD
Imipramine—Asthenia—Olmesartan—coronary artery disease	4.18e-05	0.000384	CcSEcCtD
Imipramine—Headache—Clopidogrel—coronary artery disease	4.18e-05	0.000384	CcSEcCtD
Imipramine—Rash—Lovastatin—coronary artery disease	4.18e-05	0.000384	CcSEcCtD
Imipramine—Dermatitis—Lovastatin—coronary artery disease	4.18e-05	0.000383	CcSEcCtD
Imipramine—Dyspepsia—Losartan—coronary artery disease	4.17e-05	0.000383	CcSEcCtD
Imipramine—Feeling abnormal—Perindopril—coronary artery disease	4.16e-05	0.000382	CcSEcCtD
Imipramine—Headache—Lovastatin—coronary artery disease	4.16e-05	0.000381	CcSEcCtD
Imipramine—Pruritus—Valsartan—coronary artery disease	4.15e-05	0.00038	CcSEcCtD
Imipramine—Dry mouth—Ramipril—coronary artery disease	4.15e-05	0.00038	CcSEcCtD
Imipramine—Vomiting—Ezetimibe—coronary artery disease	4.14e-05	0.000379	CcSEcCtD
Imipramine—Gastrointestinal pain—Perindopril—coronary artery disease	4.13e-05	0.000379	CcSEcCtD
Imipramine—Anxiety—Timolol—coronary artery disease	4.13e-05	0.000379	CcSEcCtD
Imipramine—Pruritus—Olmesartan—coronary artery disease	4.13e-05	0.000378	CcSEcCtD
Imipramine—Decreased appetite—Losartan—coronary artery disease	4.12e-05	0.000378	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.12e-05	0.000377	CcSEcCtD
Imipramine—Abdominal pain—Captopril—coronary artery disease	4.11e-05	0.000377	CcSEcCtD
Imipramine—Body temperature increased—Captopril—coronary artery disease	4.11e-05	0.000377	CcSEcCtD
Imipramine—Dizziness—Simvastatin—coronary artery disease	4.1e-05	0.000376	CcSEcCtD
Imipramine—Rash—Ezetimibe—coronary artery disease	4.1e-05	0.000376	CcSEcCtD
Imipramine—Dermatitis—Ezetimibe—coronary artery disease	4.1e-05	0.000376	CcSEcCtD
Imipramine—Confusional state—Ramipril—coronary artery disease	4.1e-05	0.000376	CcSEcCtD
Imipramine—Discomfort—Timolol—coronary artery disease	4.09e-05	0.000375	CcSEcCtD
Imipramine—Asthenia—Niacin—coronary artery disease	4.09e-05	0.000375	CcSEcCtD
Imipramine—Fatigue—Losartan—coronary artery disease	4.09e-05	0.000375	CcSEcCtD
Imipramine—Headache—Ezetimibe—coronary artery disease	4.08e-05	0.000374	CcSEcCtD
Imipramine—Malaise—Lisinopril—coronary artery disease	4.07e-05	0.000373	CcSEcCtD
Imipramine—Anaphylactic shock—Ramipril—coronary artery disease	4.06e-05	0.000373	CcSEcCtD
Imipramine—Oedema—Ramipril—coronary artery disease	4.06e-05	0.000373	CcSEcCtD
Imipramine—Dry mouth—Timolol—coronary artery disease	4.05e-05	0.000372	CcSEcCtD
Imipramine—Constipation—Losartan—coronary artery disease	4.05e-05	0.000372	CcSEcCtD
Imipramine—Syncope—Lisinopril—coronary artery disease	4.05e-05	0.000371	CcSEcCtD
Imipramine—Vomiting—Eplerenone—coronary artery disease	4.05e-05	0.000371	CcSEcCtD
Imipramine—Feeling abnormal—Furosemide—coronary artery disease	4.05e-05	0.000371	CcSEcCtD
Imipramine—Leukopenia—Lisinopril—coronary artery disease	4.04e-05	0.000371	CcSEcCtD
Imipramine—Nausea—Fenofibrate—coronary artery disease	4.04e-05	0.00037	CcSEcCtD
Imipramine—Pruritus—Niacin—coronary artery disease	4.03e-05	0.00037	CcSEcCtD
Imipramine—Asthenia—Pravastatin—coronary artery disease	4.02e-05	0.000369	CcSEcCtD
Imipramine—Gastrointestinal pain—Furosemide—coronary artery disease	4.02e-05	0.000368	CcSEcCtD
Imipramine—Rash—Eplerenone—coronary artery disease	4.02e-05	0.000368	CcSEcCtD
Imipramine—Urticaria—Perindopril—coronary artery disease	4.01e-05	0.000368	CcSEcCtD
Imipramine—Dermatitis—Eplerenone—coronary artery disease	4.01e-05	0.000368	CcSEcCtD
Imipramine—Diarrhoea—Valsartan—coronary artery disease	4.01e-05	0.000368	CcSEcCtD
Imipramine—Confusional state—Timolol—coronary artery disease	4.01e-05	0.000367	CcSEcCtD
Imipramine—Shock—Ramipril—coronary artery disease	4e-05	0.000367	CcSEcCtD
Imipramine—Abdominal pain—Perindopril—coronary artery disease	3.99e-05	0.000366	CcSEcCtD
Imipramine—Body temperature increased—Perindopril—coronary artery disease	3.99e-05	0.000366	CcSEcCtD
Imipramine—Palpitations—Lisinopril—coronary artery disease	3.99e-05	0.000366	CcSEcCtD
Imipramine—Diarrhoea—Olmesartan—coronary artery disease	3.99e-05	0.000366	CcSEcCtD
Imipramine—Cyclobenzaprine—HTR2A—coronary artery disease	3.99e-05	0.0152	CrCbGaD
Imipramine—Headache—Eplerenone—coronary artery disease	3.99e-05	0.000366	CcSEcCtD
Imipramine—Nervous system disorder—Ramipril—coronary artery disease	3.99e-05	0.000365	CcSEcCtD
Imipramine—Thrombocytopenia—Ramipril—coronary artery disease	3.98e-05	0.000365	CcSEcCtD
Imipramine—Oedema—Timolol—coronary artery disease	3.97e-05	0.000364	CcSEcCtD
Imipramine—Anaphylactic shock—Timolol—coronary artery disease	3.97e-05	0.000364	CcSEcCtD
Imipramine—Pruritus—Pravastatin—coronary artery disease	3.97e-05	0.000364	CcSEcCtD
Imipramine—Loss of consciousness—Lisinopril—coronary artery disease	3.97e-05	0.000364	CcSEcCtD
Imipramine—Nausea—Clopidogrel—coronary artery disease	3.97e-05	0.000364	CcSEcCtD
Imipramine—Tachycardia—Ramipril—coronary artery disease	3.97e-05	0.000364	CcSEcCtD
Imipramine—Epinastine—HTR2A—coronary artery disease	3.96e-05	0.0151	CrCbGaD
Imipramine—Skin disorder—Ramipril—coronary artery disease	3.95e-05	0.000362	CcSEcCtD
Imipramine—Infection—Timolol—coronary artery disease	3.95e-05	0.000362	CcSEcCtD
Imipramine—Vomiting—Simvastatin—coronary artery disease	3.95e-05	0.000362	CcSEcCtD
Imipramine—Nausea—Lovastatin—coronary artery disease	3.94e-05	0.000361	CcSEcCtD
Imipramine—Hyperhidrosis—Ramipril—coronary artery disease	3.93e-05	0.00036	CcSEcCtD
Imipramine—Rash—Simvastatin—coronary artery disease	3.91e-05	0.000359	CcSEcCtD
Imipramine—Dermatitis—Simvastatin—coronary artery disease	3.91e-05	0.000358	CcSEcCtD
Imipramine—Asthenia—Trandolapril—coronary artery disease	3.91e-05	0.000358	CcSEcCtD
Imipramine—Shock—Timolol—coronary artery disease	3.91e-05	0.000358	CcSEcCtD
Imipramine—Feeling abnormal—Losartan—coronary artery disease	3.91e-05	0.000358	CcSEcCtD
Imipramine—Urticaria—Furosemide—coronary artery disease	3.9e-05	0.000358	CcSEcCtD
Imipramine—Diarrhoea—Niacin—coronary artery disease	3.9e-05	0.000357	CcSEcCtD
Imipramine—Nervous system disorder—Timolol—coronary artery disease	3.9e-05	0.000357	CcSEcCtD
Imipramine—Asthenia—Enalapril—coronary artery disease	3.89e-05	0.000357	CcSEcCtD
Imipramine—Headache—Simvastatin—coronary artery disease	3.89e-05	0.000356	CcSEcCtD
Imipramine—Abdominal pain—Furosemide—coronary artery disease	3.88e-05	0.000356	CcSEcCtD
Imipramine—Body temperature increased—Furosemide—coronary artery disease	3.88e-05	0.000356	CcSEcCtD
Imipramine—Gastrointestinal pain—Losartan—coronary artery disease	3.88e-05	0.000355	CcSEcCtD
Imipramine—Dizziness—Valsartan—coronary artery disease	3.87e-05	0.000355	CcSEcCtD
Imipramine—Anorexia—Ramipril—coronary artery disease	3.87e-05	0.000355	CcSEcCtD
Imipramine—Nausea—Ezetimibe—coronary artery disease	3.86e-05	0.000354	CcSEcCtD
Imipramine—Skin disorder—Timolol—coronary artery disease	3.86e-05	0.000354	CcSEcCtD
Imipramine—Dizziness—Olmesartan—coronary artery disease	3.86e-05	0.000354	CcSEcCtD
Imipramine—Pruritus—Trandolapril—coronary artery disease	3.85e-05	0.000353	CcSEcCtD
Imipramine—Hyperhidrosis—Timolol—coronary artery disease	3.84e-05	0.000352	CcSEcCtD
Imipramine—Asthenia—Telmisartan—coronary artery disease	3.84e-05	0.000352	CcSEcCtD
Imipramine—Pruritus—Enalapril—coronary artery disease	3.84e-05	0.000352	CcSEcCtD
Imipramine—Diarrhoea—Pravastatin—coronary artery disease	3.84e-05	0.000352	CcSEcCtD
Imipramine—Anxiety—Lisinopril—coronary artery disease	3.83e-05	0.000351	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.82e-05	0.00035	CcSEcCtD
Imipramine—Discomfort—Lisinopril—coronary artery disease	3.8e-05	0.000348	CcSEcCtD
Imipramine—Anorexia—Timolol—coronary artery disease	3.79e-05	0.000347	CcSEcCtD
Imipramine—Pruritus—Telmisartan—coronary artery disease	3.79e-05	0.000347	CcSEcCtD
Imipramine—Nausea—Eplerenone—coronary artery disease	3.78e-05	0.000347	CcSEcCtD
Imipramine—Dizziness—Niacin—coronary artery disease	3.77e-05	0.000346	CcSEcCtD
Imipramine—Urticaria—Losartan—coronary artery disease	3.76e-05	0.000345	CcSEcCtD
Imipramine—Dry mouth—Lisinopril—coronary artery disease	3.76e-05	0.000345	CcSEcCtD
Imipramine—Body temperature increased—Losartan—coronary artery disease	3.75e-05	0.000344	CcSEcCtD
Imipramine—Abdominal pain—Losartan—coronary artery disease	3.75e-05	0.000344	CcSEcCtD
Imipramine—Asthenia—Captopril—coronary artery disease	3.73e-05	0.000342	CcSEcCtD
Imipramine—Diarrhoea—Trandolapril—coronary artery disease	3.73e-05	0.000342	CcSEcCtD
Imipramine—Vomiting—Valsartan—coronary artery disease	3.73e-05	0.000342	CcSEcCtD
Imipramine—Confusional state—Lisinopril—coronary artery disease	3.72e-05	0.000341	CcSEcCtD
Imipramine—Diarrhoea—Enalapril—coronary artery disease	3.71e-05	0.00034	CcSEcCtD
Imipramine—Dizziness—Pravastatin—coronary artery disease	3.71e-05	0.00034	CcSEcCtD
Imipramine—Vomiting—Olmesartan—coronary artery disease	3.71e-05	0.00034	CcSEcCtD
Imipramine—Rash—Valsartan—coronary artery disease	3.69e-05	0.000339	CcSEcCtD
Imipramine—Dermatitis—Valsartan—coronary artery disease	3.69e-05	0.000339	CcSEcCtD
Imipramine—Nausea—Simvastatin—coronary artery disease	3.69e-05	0.000338	CcSEcCtD
Imipramine—Anaphylactic shock—Lisinopril—coronary artery disease	3.69e-05	0.000338	CcSEcCtD
Imipramine—Oedema—Lisinopril—coronary artery disease	3.69e-05	0.000338	CcSEcCtD
Imipramine—Pruritus—Captopril—coronary artery disease	3.68e-05	0.000338	CcSEcCtD
Imipramine—Rash—Olmesartan—coronary artery disease	3.68e-05	0.000337	CcSEcCtD
Imipramine—Insomnia—Ramipril—coronary artery disease	3.68e-05	0.000337	CcSEcCtD
Imipramine—Dermatitis—Olmesartan—coronary artery disease	3.67e-05	0.000337	CcSEcCtD
Imipramine—Headache—Valsartan—coronary artery disease	3.67e-05	0.000337	CcSEcCtD
Imipramine—Diarrhoea—Telmisartan—coronary artery disease	3.66e-05	0.000336	CcSEcCtD
Imipramine—Infection—Lisinopril—coronary artery disease	3.66e-05	0.000336	CcSEcCtD
Imipramine—Headache—Olmesartan—coronary artery disease	3.65e-05	0.000335	CcSEcCtD
Imipramine—Paraesthesia—Ramipril—coronary artery disease	3.65e-05	0.000335	CcSEcCtD
Imipramine—Shock—Lisinopril—coronary artery disease	3.63e-05	0.000333	CcSEcCtD
Imipramine—Asthenia—Perindopril—coronary artery disease	3.63e-05	0.000332	CcSEcCtD
Imipramine—Vomiting—Niacin—coronary artery disease	3.62e-05	0.000332	CcSEcCtD
Imipramine—Somnolence—Ramipril—coronary artery disease	3.61e-05	0.000331	CcSEcCtD
Imipramine—Thrombocytopenia—Lisinopril—coronary artery disease	3.61e-05	0.000331	CcSEcCtD
Imipramine—Dizziness—Trandolapril—coronary artery disease	3.6e-05	0.00033	CcSEcCtD
Imipramine—Tachycardia—Lisinopril—coronary artery disease	3.6e-05	0.00033	CcSEcCtD
Imipramine—Insomnia—Timolol—coronary artery disease	3.59e-05	0.00033	CcSEcCtD
Imipramine—Rash—Niacin—coronary artery disease	3.59e-05	0.000329	CcSEcCtD
Imipramine—Dermatitis—Niacin—coronary artery disease	3.59e-05	0.000329	CcSEcCtD
Imipramine—Dizziness—Enalapril—coronary artery disease	3.59e-05	0.000329	CcSEcCtD
Imipramine—Skin disorder—Lisinopril—coronary artery disease	3.58e-05	0.000328	CcSEcCtD
Imipramine—Dyspepsia—Ramipril—coronary artery disease	3.58e-05	0.000328	CcSEcCtD
Imipramine—Pruritus—Perindopril—coronary artery disease	3.57e-05	0.000328	CcSEcCtD
Imipramine—Headache—Niacin—coronary artery disease	3.57e-05	0.000327	CcSEcCtD
Imipramine—Paraesthesia—Timolol—coronary artery disease	3.57e-05	0.000327	CcSEcCtD
Imipramine—Vomiting—Pravastatin—coronary artery disease	3.57e-05	0.000327	CcSEcCtD
Imipramine—Hyperhidrosis—Lisinopril—coronary artery disease	3.56e-05	0.000327	CcSEcCtD
Imipramine—Diarrhoea—Captopril—coronary artery disease	3.56e-05	0.000327	CcSEcCtD
Imipramine—Dizziness—Telmisartan—coronary artery disease	3.54e-05	0.000325	CcSEcCtD
Imipramine—Rash—Pravastatin—coronary artery disease	3.54e-05	0.000324	CcSEcCtD
Imipramine—Dermatitis—Pravastatin—coronary artery disease	3.53e-05	0.000324	CcSEcCtD
Imipramine—Decreased appetite—Ramipril—coronary artery disease	3.53e-05	0.000324	CcSEcCtD
Imipramine—Somnolence—Timolol—coronary artery disease	3.53e-05	0.000324	CcSEcCtD
Imipramine—Asthenia—Furosemide—coronary artery disease	3.52e-05	0.000323	CcSEcCtD
Imipramine—Headache—Pravastatin—coronary artery disease	3.51e-05	0.000322	CcSEcCtD
Imipramine—Anorexia—Lisinopril—coronary artery disease	3.51e-05	0.000322	CcSEcCtD
Imipramine—Gastrointestinal disorder—Ramipril—coronary artery disease	3.51e-05	0.000322	CcSEcCtD
Imipramine—Fatigue—Ramipril—coronary artery disease	3.5e-05	0.000321	CcSEcCtD
Imipramine—Dyspepsia—Timolol—coronary artery disease	3.5e-05	0.000321	CcSEcCtD
Imipramine—Nausea—Valsartan—coronary artery disease	3.48e-05	0.000319	CcSEcCtD
Imipramine—Pruritus—Furosemide—coronary artery disease	3.47e-05	0.000319	CcSEcCtD
Imipramine—Constipation—Ramipril—coronary artery disease	3.47e-05	0.000319	CcSEcCtD
Imipramine—Nausea—Olmesartan—coronary artery disease	3.46e-05	0.000318	CcSEcCtD
Imipramine—Vomiting—Trandolapril—coronary artery disease	3.46e-05	0.000318	CcSEcCtD
Imipramine—Diarrhoea—Perindopril—coronary artery disease	3.46e-05	0.000317	CcSEcCtD
Imipramine—Decreased appetite—Timolol—coronary artery disease	3.45e-05	0.000317	CcSEcCtD
Imipramine—Vomiting—Enalapril—coronary artery disease	3.45e-05	0.000316	CcSEcCtD
Imipramine—Dizziness—Captopril—coronary artery disease	3.44e-05	0.000316	CcSEcCtD
Imipramine—Rash—Trandolapril—coronary artery disease	3.43e-05	0.000315	CcSEcCtD
Imipramine—Dermatitis—Trandolapril—coronary artery disease	3.43e-05	0.000315	CcSEcCtD
Imipramine—Gastrointestinal disorder—Timolol—coronary artery disease	3.43e-05	0.000315	CcSEcCtD
Imipramine—Fatigue—Timolol—coronary artery disease	3.42e-05	0.000314	CcSEcCtD
Imipramine—Rash—Enalapril—coronary artery disease	3.42e-05	0.000314	CcSEcCtD
Imipramine—Dermatitis—Enalapril—coronary artery disease	3.42e-05	0.000313	CcSEcCtD
Imipramine—Headache—Trandolapril—coronary artery disease	3.41e-05	0.000313	CcSEcCtD
Imipramine—Maprotiline—HTR2A—coronary artery disease	3.41e-05	0.013	CrCbGaD
Imipramine—Vomiting—Telmisartan—coronary artery disease	3.4e-05	0.000312	CcSEcCtD
Imipramine—Asthenia—Losartan—coronary artery disease	3.4e-05	0.000312	CcSEcCtD
Imipramine—Headache—Enalapril—coronary artery disease	3.4e-05	0.000312	CcSEcCtD
Imipramine—Nausea—Niacin—coronary artery disease	3.38e-05	0.00031	CcSEcCtD
Imipramine—Rash—Telmisartan—coronary artery disease	3.37e-05	0.000309	CcSEcCtD
Imipramine—Dermatitis—Telmisartan—coronary artery disease	3.37e-05	0.000309	CcSEcCtD
Imipramine—Diarrhoea—Furosemide—coronary artery disease	3.36e-05	0.000308	CcSEcCtD
Imipramine—Pruritus—Losartan—coronary artery disease	3.35e-05	0.000307	CcSEcCtD
Imipramine—Headache—Telmisartan—coronary artery disease	3.35e-05	0.000307	CcSEcCtD
Imipramine—Feeling abnormal—Ramipril—coronary artery disease	3.35e-05	0.000307	CcSEcCtD
Imipramine—Dizziness—Perindopril—coronary artery disease	3.34e-05	0.000306	CcSEcCtD
Imipramine—Insomnia—Lisinopril—coronary artery disease	3.33e-05	0.000306	CcSEcCtD
Imipramine—Nausea—Pravastatin—coronary artery disease	3.33e-05	0.000306	CcSEcCtD
Imipramine—Gastrointestinal pain—Ramipril—coronary artery disease	3.32e-05	0.000305	CcSEcCtD
Imipramine—Paraesthesia—Lisinopril—coronary artery disease	3.31e-05	0.000303	CcSEcCtD
Imipramine—Vomiting—Captopril—coronary artery disease	3.31e-05	0.000303	CcSEcCtD
Imipramine—Rash—Captopril—coronary artery disease	3.28e-05	0.000301	CcSEcCtD
Imipramine—Dermatitis—Captopril—coronary artery disease	3.28e-05	0.000301	CcSEcCtD
Imipramine—Somnolence—Lisinopril—coronary artery disease	3.28e-05	0.0003	CcSEcCtD
Imipramine—Feeling abnormal—Timolol—coronary artery disease	3.27e-05	0.0003	CcSEcCtD
Imipramine—Pipotiazine—CYP2C19—coronary artery disease	3.27e-05	0.0124	CrCbGaD
Imipramine—Headache—Captopril—coronary artery disease	3.26e-05	0.000299	CcSEcCtD
Imipramine—Gastrointestinal pain—Timolol—coronary artery disease	3.25e-05	0.000298	CcSEcCtD
Imipramine—Dizziness—Furosemide—coronary artery disease	3.25e-05	0.000298	CcSEcCtD
Imipramine—Dyspepsia—Lisinopril—coronary artery disease	3.24e-05	0.000297	CcSEcCtD
Imipramine—Diarrhoea—Losartan—coronary artery disease	3.24e-05	0.000297	CcSEcCtD
Imipramine—Nausea—Trandolapril—coronary artery disease	3.24e-05	0.000297	CcSEcCtD
Imipramine—Urticaria—Ramipril—coronary artery disease	3.23e-05	0.000296	CcSEcCtD
Imipramine—Nausea—Enalapril—coronary artery disease	3.22e-05	0.000296	CcSEcCtD
Imipramine—Vomiting—Perindopril—coronary artery disease	3.21e-05	0.000295	CcSEcCtD
Imipramine—Abdominal pain—Ramipril—coronary artery disease	3.21e-05	0.000295	CcSEcCtD
Imipramine—Body temperature increased—Ramipril—coronary artery disease	3.21e-05	0.000295	CcSEcCtD
Imipramine—Decreased appetite—Lisinopril—coronary artery disease	3.2e-05	0.000294	CcSEcCtD
Imipramine—Rash—Perindopril—coronary artery disease	3.19e-05	0.000292	CcSEcCtD
Imipramine—Dermatitis—Perindopril—coronary artery disease	3.18e-05	0.000292	CcSEcCtD
Imipramine—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.18e-05	0.000292	CcSEcCtD
Imipramine—Nausea—Telmisartan—coronary artery disease	3.18e-05	0.000292	CcSEcCtD
Imipramine—Fatigue—Lisinopril—coronary artery disease	3.18e-05	0.000291	CcSEcCtD
Imipramine—Headache—Perindopril—coronary artery disease	3.17e-05	0.00029	CcSEcCtD
Imipramine—Urticaria—Timolol—coronary artery disease	3.16e-05	0.000289	CcSEcCtD
Imipramine—Constipation—Lisinopril—coronary artery disease	3.15e-05	0.000289	CcSEcCtD
Imipramine—Abdominal pain—Timolol—coronary artery disease	3.14e-05	0.000288	CcSEcCtD
Imipramine—Body temperature increased—Timolol—coronary artery disease	3.14e-05	0.000288	CcSEcCtD
Imipramine—Dizziness—Losartan—coronary artery disease	3.13e-05	0.000287	CcSEcCtD
Imipramine—Vomiting—Furosemide—coronary artery disease	3.12e-05	0.000286	CcSEcCtD
Imipramine—Rash—Furosemide—coronary artery disease	3.1e-05	0.000284	CcSEcCtD
Imipramine—Dermatitis—Furosemide—coronary artery disease	3.09e-05	0.000284	CcSEcCtD
Imipramine—Nausea—Captopril—coronary artery disease	3.09e-05	0.000283	CcSEcCtD
Imipramine—Headache—Furosemide—coronary artery disease	3.08e-05	0.000282	CcSEcCtD
Imipramine—Carbamazepine—CYP2C19—coronary artery disease	3.07e-05	0.0117	CrCbGaD
Imipramine—Feeling abnormal—Lisinopril—coronary artery disease	3.04e-05	0.000279	CcSEcCtD
Imipramine—Gastrointestinal pain—Lisinopril—coronary artery disease	3.01e-05	0.000276	CcSEcCtD
Imipramine—Vomiting—Losartan—coronary artery disease	3.01e-05	0.000276	CcSEcCtD
Imipramine—Nausea—Perindopril—coronary artery disease	3e-05	0.000275	CcSEcCtD
Imipramine—Rash—Losartan—coronary artery disease	2.99e-05	0.000274	CcSEcCtD
Imipramine—Dermatitis—Losartan—coronary artery disease	2.99e-05	0.000274	CcSEcCtD
Imipramine—Headache—Losartan—coronary artery disease	2.97e-05	0.000272	CcSEcCtD
Imipramine—Urticaria—Lisinopril—coronary artery disease	2.93e-05	0.000268	CcSEcCtD
Imipramine—Nausea—Furosemide—coronary artery disease	2.92e-05	0.000268	CcSEcCtD
Imipramine—Asthenia—Ramipril—coronary artery disease	2.92e-05	0.000267	CcSEcCtD
Imipramine—Abdominal pain—Lisinopril—coronary artery disease	2.91e-05	0.000267	CcSEcCtD
Imipramine—Body temperature increased—Lisinopril—coronary artery disease	2.91e-05	0.000267	CcSEcCtD
Imipramine—Pruritus—Ramipril—coronary artery disease	2.87e-05	0.000264	CcSEcCtD
Imipramine—Desipramine—ADRB1—coronary artery disease	2.87e-05	0.0109	CrCbGaD
Imipramine—Chlorpromazine—HTR7—coronary artery disease	2.86e-05	0.0109	CrCbGaD
Imipramine—Asthenia—Timolol—coronary artery disease	2.85e-05	0.000261	CcSEcCtD
Imipramine—Amitriptyline—HTR7—coronary artery disease	2.83e-05	0.0107	CrCbGaD
Imipramine—Nausea—Losartan—coronary artery disease	2.81e-05	0.000258	CcSEcCtD
Imipramine—Pruritus—Timolol—coronary artery disease	2.81e-05	0.000258	CcSEcCtD
Imipramine—Diarrhoea—Ramipril—coronary artery disease	2.78e-05	0.000255	CcSEcCtD
Imipramine—Acepromazine—HTR2A—coronary artery disease	2.76e-05	0.0105	CrCbGaD
Imipramine—Diarrhoea—Timolol—coronary artery disease	2.72e-05	0.000249	CcSEcCtD
Imipramine—Thioproperazine—HTR2A—coronary artery disease	2.69e-05	0.0102	CrCbGaD
Imipramine—Dizziness—Ramipril—coronary artery disease	2.69e-05	0.000246	CcSEcCtD
Imipramine—Pipotiazine—HTR2A—coronary artery disease	2.65e-05	0.0101	CrCbGaD
Imipramine—Asthenia—Lisinopril—coronary artery disease	2.64e-05	0.000242	CcSEcCtD
Imipramine—Dizziness—Timolol—coronary artery disease	2.63e-05	0.000241	CcSEcCtD
Imipramine—Pruritus—Lisinopril—coronary artery disease	2.61e-05	0.000239	CcSEcCtD
Imipramine—Clomipramine—CYP2C19—coronary artery disease	2.59e-05	0.00983	CrCbGaD
Imipramine—Vomiting—Ramipril—coronary artery disease	2.58e-05	0.000237	CcSEcCtD
Imipramine—Rash—Ramipril—coronary artery disease	2.56e-05	0.000235	CcSEcCtD
Imipramine—Dermatitis—Ramipril—coronary artery disease	2.56e-05	0.000235	CcSEcCtD
Imipramine—Headache—Ramipril—coronary artery disease	2.55e-05	0.000233	CcSEcCtD
Imipramine—Nortriptyline—CYP2C19—coronary artery disease	2.53e-05	0.00961	CrCbGaD
Imipramine—Vomiting—Timolol—coronary artery disease	2.53e-05	0.000232	CcSEcCtD
Imipramine—Diarrhoea—Lisinopril—coronary artery disease	2.52e-05	0.000231	CcSEcCtD
Imipramine—Rash—Timolol—coronary artery disease	2.5e-05	0.00023	CcSEcCtD
Imipramine—Dermatitis—Timolol—coronary artery disease	2.5e-05	0.000229	CcSEcCtD
Imipramine—Oxcarbazepine—ALB—coronary artery disease	2.5e-05	0.00949	CrCbGaD
Imipramine—Headache—Timolol—coronary artery disease	2.49e-05	0.000228	CcSEcCtD
Imipramine—Dizziness—Lisinopril—coronary artery disease	2.44e-05	0.000223	CcSEcCtD
Imipramine—Desipramine—ADRB2—coronary artery disease	2.42e-05	0.00919	CrCbGaD
Imipramine—Nausea—Ramipril—coronary artery disease	2.41e-05	0.000221	CcSEcCtD
Imipramine—Trimipramine—CYP2C19—coronary artery disease	2.38e-05	0.00904	CrCbGaD
Imipramine—Nausea—Timolol—coronary artery disease	2.36e-05	0.000216	CcSEcCtD
Imipramine—Vomiting—Lisinopril—coronary artery disease	2.34e-05	0.000215	CcSEcCtD
Imipramine—Diphenhydramine—CYP2C19—coronary artery disease	2.34e-05	0.00888	CrCbGaD
Imipramine—Rash—Lisinopril—coronary artery disease	2.32e-05	0.000213	CcSEcCtD
Imipramine—Dermatitis—Lisinopril—coronary artery disease	2.32e-05	0.000213	CcSEcCtD
Imipramine—Headache—Lisinopril—coronary artery disease	2.31e-05	0.000212	CcSEcCtD
Imipramine—Mianserin—HTR2A—coronary artery disease	2.29e-05	0.00871	CrCbGaD
Imipramine—Doxepin—CYP2C19—coronary artery disease	2.27e-05	0.00862	CrCbGaD
Imipramine—Nausea—Lisinopril—coronary artery disease	2.19e-05	0.000201	CcSEcCtD
Imipramine—Clomipramine—HTR2A—coronary artery disease	2.1e-05	0.00797	CrCbGaD
Imipramine—Desipramine—CYP2C19—coronary artery disease	2.08e-05	0.00791	CrCbGaD
Imipramine—Nortriptyline—HTR2A—coronary artery disease	2.05e-05	0.00779	CrCbGaD
Imipramine—Promazine—CYP2C19—coronary artery disease	2.01e-05	0.00766	CrCbGaD
Imipramine—Trimipramine—HTR2A—coronary artery disease	1.93e-05	0.00733	CrCbGaD
Imipramine—Acepromazine—ALB—coronary artery disease	1.89e-05	0.00717	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—coronary artery disease	1.88e-05	0.00717	CrCbGaD
Imipramine—Promethazine—HTR2A—coronary artery disease	1.86e-05	0.00706	CrCbGaD
Imipramine—Thioproperazine—ALB—coronary artery disease	1.84e-05	0.00701	CrCbGaD
Imipramine—Doxepin—HTR2A—coronary artery disease	1.84e-05	0.00699	CrCbGaD
Imipramine—Pipotiazine—ALB—coronary artery disease	1.81e-05	0.0069	CrCbGaD
Imipramine—Amitriptyline—CYP2C19—coronary artery disease	1.75e-05	0.00667	CrCbGaD
Imipramine—Desipramine—HTR2A—coronary artery disease	1.69e-05	0.00641	CrCbGaD
Imipramine—Promazine—HTR2A—coronary artery disease	1.63e-05	0.00621	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—coronary artery disease	1.44e-05	0.00547	CrCbGaD
Imipramine—Clomipramine—ALB—coronary artery disease	1.43e-05	0.00545	CrCbGaD
Imipramine—Amitriptyline—HTR2A—coronary artery disease	1.42e-05	0.0054	CrCbGaD
Imipramine—Nortriptyline—ALB—coronary artery disease	1.4e-05	0.00533	CrCbGaD
Imipramine—Chlorpromazine—ALB—coronary artery disease	9.84e-06	0.00374	CrCbGaD
Imipramine—Amitriptyline—ALB—coronary artery disease	9.72e-06	0.0037	CrCbGaD
Imipramine—ABCB1—Metabolism—APOA1—coronary artery disease	6.57e-07	8.02e-06	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	6.56e-07	8.01e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	6.56e-07	8.01e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—JAK2—coronary artery disease	6.54e-07	7.98e-06	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	6.53e-07	7.97e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	6.5e-07	7.94e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	6.5e-07	7.93e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	6.48e-07	7.91e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	6.47e-07	7.9e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	6.47e-07	7.9e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	6.46e-07	7.89e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	6.45e-07	7.88e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTM1—coronary artery disease	6.45e-07	7.87e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.44e-07	7.87e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	6.43e-07	7.85e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	6.43e-07	7.84e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.42e-07	7.84e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—JAK2—coronary artery disease	6.42e-07	7.83e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	6.41e-07	7.82e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	6.4e-07	7.81e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGT—coronary artery disease	6.39e-07	7.8e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	6.38e-07	7.78e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	6.33e-07	7.73e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	6.33e-07	7.73e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	6.33e-07	7.73e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—LPL—coronary artery disease	6.33e-07	7.72e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	6.31e-07	7.71e-06	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—coronary artery disease	6.31e-07	7.7e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	6.3e-07	7.69e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	6.3e-07	7.69e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	6.3e-07	7.69e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	6.29e-07	7.68e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	6.27e-07	7.65e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—coronary artery disease	6.26e-07	7.64e-06	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	6.25e-07	7.63e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	6.25e-07	7.63e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.22e-07	7.6e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	6.19e-07	7.56e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOA1—coronary artery disease	6.19e-07	7.56e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	6.19e-07	7.55e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	6.18e-07	7.54e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GPX1—coronary artery disease	6.17e-07	7.54e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—coronary artery disease	6.17e-07	7.53e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	6.17e-07	7.53e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	6.15e-07	7.51e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	6.15e-07	7.5e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	6.11e-07	7.46e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	6.06e-07	7.4e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—coronary artery disease	6.05e-07	7.38e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GGT1—coronary artery disease	6.03e-07	7.36e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GOT1—coronary artery disease	6.03e-07	7.36e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	6.03e-07	7.36e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CD36—coronary artery disease	6.01e-07	7.34e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	5.97e-07	7.28e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	5.96e-07	7.27e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	5.94e-07	7.25e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—coronary artery disease	5.93e-07	7.24e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	5.93e-07	7.24e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	5.87e-07	7.16e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	5.86e-07	7.15e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	5.85e-07	7.14e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—POMC—coronary artery disease	5.85e-07	7.14e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	5.84e-07	7.13e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	5.82e-07	7.11e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	5.82e-07	7.1e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	5.82e-07	7.1e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	5.81e-07	7.09e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—coronary artery disease	5.79e-07	7.06e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	5.76e-07	7.03e-06	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	5.76e-07	7.03e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	5.75e-07	7.01e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—coronary artery disease	5.71e-07	6.97e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—POMC—coronary artery disease	5.71e-07	6.97e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	5.7e-07	6.96e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—coronary artery disease	5.7e-07	6.95e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	5.68e-07	6.93e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—coronary artery disease	5.67e-07	6.92e-06	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	5.67e-07	6.92e-06	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	5.66e-07	6.91e-06	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	5.64e-07	6.88e-06	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	5.62e-07	6.86e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	5.62e-07	6.86e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—coronary artery disease	5.61e-07	6.84e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	5.59e-07	6.82e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	5.58e-07	6.81e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	5.57e-07	6.8e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—coronary artery disease	5.57e-07	6.8e-06	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	5.57e-07	6.8e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCND1—coronary artery disease	5.56e-07	6.78e-06	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	5.55e-07	6.78e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	5.55e-07	6.78e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	5.53e-07	6.75e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	5.52e-07	6.74e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	5.52e-07	6.73e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	5.5e-07	6.71e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	5.49e-07	6.7e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	5.49e-07	6.7e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	5.48e-07	6.69e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	5.47e-07	6.67e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	5.47e-07	6.67e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCND1—coronary artery disease	5.46e-07	6.66e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—coronary artery disease	5.45e-07	6.66e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	5.44e-07	6.64e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	5.42e-07	6.62e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.42e-07	6.61e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGT—coronary artery disease	5.41e-07	6.61e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—coronary artery disease	5.4e-07	6.59e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—coronary artery disease	5.38e-07	6.57e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	5.37e-07	6.55e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.37e-07	6.55e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	5.35e-07	6.54e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.34e-07	6.52e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—coronary artery disease	5.33e-07	6.51e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	5.31e-07	6.48e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—coronary artery disease	5.31e-07	6.47e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—coronary artery disease	5.3e-07	6.47e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	5.28e-07	6.45e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—coronary artery disease	5.27e-07	6.43e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	5.26e-07	6.42e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	5.26e-07	6.42e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	5.26e-07	6.41e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOA1—coronary artery disease	5.24e-07	6.4e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	5.23e-07	6.39e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	5.21e-07	6.36e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—coronary artery disease	5.2e-07	6.35e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	5.2e-07	6.34e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—coronary artery disease	5.16e-07	6.29e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—coronary artery disease	5.15e-07	6.29e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	5.15e-07	6.28e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	5.14e-07	6.27e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—coronary artery disease	5.14e-07	6.27e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—coronary artery disease	5.13e-07	6.26e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	5.12e-07	6.25e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOB—coronary artery disease	5.12e-07	6.24e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	5.11e-07	6.23e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—coronary artery disease	5.1e-07	6.23e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	5.06e-07	6.18e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	5.06e-07	6.17e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	5.04e-07	6.15e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	5.04e-07	6.15e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.02e-07	6.13e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—coronary artery disease	4.98e-07	6.08e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.98e-07	6.07e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	4.97e-07	6.06e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	4.95e-07	6.04e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	4.94e-07	6.03e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—coronary artery disease	4.9e-07	5.99e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LPL—coronary artery disease	4.88e-07	5.96e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—coronary artery disease	4.86e-07	5.94e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	4.85e-07	5.91e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	4.82e-07	5.89e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—coronary artery disease	4.78e-07	5.83e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	4.77e-07	5.82e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—coronary artery disease	4.77e-07	5.82e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	4.76e-07	5.81e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—coronary artery disease	4.76e-07	5.81e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—coronary artery disease	4.75e-07	5.8e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	4.74e-07	5.79e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	4.73e-07	5.77e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	4.73e-07	5.77e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—coronary artery disease	4.69e-07	5.73e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	4.68e-07	5.71e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	4.67e-07	5.7e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—coronary artery disease	4.67e-07	5.69e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—coronary artery disease	4.66e-07	5.68e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CD36—coronary artery disease	4.64e-07	5.66e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—coronary artery disease	4.62e-07	5.64e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.58e-07	5.59e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—coronary artery disease	4.56e-07	5.56e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—coronary artery disease	4.55e-07	5.56e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	4.49e-07	5.48e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	4.45e-07	5.43e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—coronary artery disease	4.42e-07	5.39e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.4e-07	5.37e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	4.38e-07	5.34e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	4.38e-07	5.34e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	4.37e-07	5.33e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	4.36e-07	5.32e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	4.35e-07	5.31e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	4.34e-07	5.29e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	4.31e-07	5.26e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	4.3e-07	5.24e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	4.3e-07	5.24e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	4.29e-07	5.24e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—coronary artery disease	4.29e-07	5.24e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	4.29e-07	5.23e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	4.28e-07	5.23e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	4.28e-07	5.23e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	4.27e-07	5.21e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	4.25e-07	5.19e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	4.21e-07	5.14e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	4.2e-07	5.13e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—coronary artery disease	4.2e-07	5.12e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—coronary artery disease	4.19e-07	5.11e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGT—coronary artery disease	4.18e-07	5.1e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—coronary artery disease	4.16e-07	5.07e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	4.1e-07	5.01e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—coronary artery disease	4.09e-07	5e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOA1—coronary artery disease	4.05e-07	4.94e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	4.04e-07	4.93e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—coronary artery disease	3.97e-07	4.85e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—coronary artery disease	3.9e-07	4.77e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—coronary artery disease	3.82e-07	4.66e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	3.8e-07	4.64e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—coronary artery disease	3.8e-07	4.63e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	3.78e-07	4.62e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	3.72e-07	4.54e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—coronary artery disease	3.72e-07	4.54e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	3.72e-07	4.53e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	3.7e-07	4.52e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	3.69e-07	4.51e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	3.66e-07	4.46e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	3.65e-07	4.45e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.64e-07	4.44e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	3.63e-07	4.44e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—coronary artery disease	3.61e-07	4.4e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—coronary artery disease	3.57e-07	4.35e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	3.52e-07	4.3e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—coronary artery disease	3.52e-07	4.29e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	3.5e-07	4.28e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	3.35e-07	4.09e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—coronary artery disease	3.35e-07	4.09e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—coronary artery disease	3.3e-07	4.02e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—coronary artery disease	3.29e-07	4.02e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—coronary artery disease	3.28e-07	4e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—coronary artery disease	3.27e-07	3.99e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—coronary artery disease	3.24e-07	3.95e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	3.23e-07	3.94e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—coronary artery disease	3.21e-07	3.91e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—coronary artery disease	3.1e-07	3.79e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—coronary artery disease	3.09e-07	3.77e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—coronary artery disease	3.07e-07	3.74e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	3.04e-07	3.71e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—coronary artery disease	3.04e-07	3.71e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—coronary artery disease	3.04e-07	3.7e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	3.03e-07	3.69e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	3.02e-07	3.68e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.99e-07	3.65e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	2.98e-07	3.64e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	2.87e-07	3.5e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.81e-07	3.42e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.8e-07	3.42e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.64e-07	3.22e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—coronary artery disease	2.34e-07	2.86e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—coronary artery disease	2.29e-07	2.79e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.24e-07	2.73e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—coronary artery disease	2.16e-07	2.63e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—coronary artery disease	1.83e-07	2.23e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.73e-07	2.11e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.41e-07	1.72e-06	CbGpPWpGaD
